In patients with non-alcoholic fatty liver disease (NAFLD) serum levels of caspase-cleaved K18 correlated with the extent of liver steatosis and liver injury (Joka et al. 2012; Tamimi et al. 2011). This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.